(Q62110326)
Statements
A Phase I/II Study of Targeted Radiotherapy Using Holmium-166-DOTMP With Melphalan and Peripheral Blood Stem Cell Transplantation for Treatment of Multiple Myeloma (English)
0 references
June 1999
0 references
clinical trial
No description defined